中国药房2017，Vol.28Issue(11)：1459-1462,4.DOI:10.6039/j.issn.1001-0408.2017.11.06
我院非瓣膜性房颤患者抗凝治疗现状调查分析
Investigation and Analysis of the Anticoagulant Therapy for Patients with Non-valvular Atrial Fibrillation in Our Hospital
摘要
Abstract
OBJECTIVE:To investigate the current situation of anticoagulant therapy for patients with non-valvular atrial fibril-lation,and to provide reference for standardized anticoagulant therapy. METHODS:A total of 1056 patients with non-valvular atri-al fibrillation were collected from our hospital during Jul. 2015-Jun. 2016. According to 2012 European Society of Cardiology Guide-lines for the Management of Atrial Fibrillation,the risks of thrombosis and hemorrhage were evaluated,and the standardized anti-coagulant therapy was also evaluated. RESULTS:Among 1056 patients with non-valvular atrial fibrillation,the number of patients with thrombosis risk score ≥1 was 1028,accounting for 97.3%. 763 patients received antithrombosis therapy,and only 139 pa-tients were given warfarin anticoagulant therapy. The international normalized ratio(INR)of prothrombin time in just 30.9% of pa-tients receiving warfarin was in line with the standard before discharge. CONCLUSIONS:The anticoagulant therapy for patients with non-valvular atrial fibrillation is still not optimistic,and effective measure should be adopted to improve the standardization of anticoagulant therapy in the patients with atrial fibrillation.关键词
非瓣膜性心房颤动/华法林/抗凝/调查Key words
Non-valvular atrial fibrillation/Warfarin/Anticoagulant/Investigation分类
医药卫生引用本文复制引用
王长江,费爱丽,朱航,王小琴,涂厉标..我院非瓣膜性房颤患者抗凝治疗现状调查分析[J].中国药房,2017,28(11):1459-1462,4.基金项目
浙江省药学会医院药学专项科研资助项目(No.2013ZYY16) （No.2013ZYY16）
嘉兴市科技计划项目(No.2015C23017) （No.2015C23017）
